Eesti -
eesti -
Ravimiamet
differin kreem
galderma international - adapaleen - kreem - 1mg 1g 5g 1tk; 1mg 1g 30g 1tk
Eesti -
eesti -
Ravimiamet
differin kreem
ideal trade links uab - adapaleen - kreem - 1mg 1g 30g 2tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - sead - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
Eesti -
eesti -
Ravimiamet
differin geel
galderma international - adapaleen - geel - 1mg 1g 5g 1tk; 1mg 1g 30g 1tk
Eesti -
eesti -
Ravimiamet
duac gel geel
stiefel laboratories legacy (ireland) limited - klindamütsiin+bensoüülperoksiid - geel - 10mg+50mg 1g 25g 1tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
lenvima
eisai gmbh - lenvatinibmesülaat - kilpnäärme kasvajad - antineoplastilised ained - lenvima on näidustatud monotherapy raviks täiskasvanud patsientidel, kellel on progresseeruv, lokaalselt kaugelearenenud või metastaatilise, liigendatud (papillary/follikulaarne/hürthle cell) kilpnäärme kartsinoom (dtc), rasksulavad, et radioaktiivse joodi (rai). lenvima on näidustatud monotherapy raviks täiskasvanud patsientidel, kaugelearenenud või unresectable hepatotsellulaarne kartsinoom (hcc), kes on saanud ilma eelneva süsteemse ravi.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfate, tazobactam naatrium - bakteriaalsed infektsioonid - antibacterials süsteemseks kasutamiseks, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.